Search Results

You are looking at 1 - 2 of 2 items for

  • Author or Editor: John Lew x
  • Refine by Access: All Content x
Clear All Modify Search


Objective—To assess antiulcerogenic properties of 3 dietary oils.

Animals—8 healthy adult mares.

Procedure—A protocol to induce gastric ulcers was used and included 240 mL of water plus corn oil, refined rice bran oil, or crude rice bran oil administered each day for 6 weeks according to a 4 × 4 Latin square randomized crossover design with 5-week washout intervals. A 7-day alternating feed deprivation period was included between weeks 5 and 6. Omeprazole was administered daily for the last 14 days of each washout interval. Endoscopic examinations of the stomach were performed at 0, 5, and 6 weeks, and the number (0 to 4 scale) and severity (0 to 5 scale) of ulcers were scored. Gastric fluid was collected at 0 and 5 weeks.

Results—Median body weight significantly increased by 29 kg (range, 10 to 50 kg). Mean ± SE gastric fluid pH significantly decreased from 4.9 ± 0.4 to 3.1 ± 0.3 over 5 weeks, and total volatile fatty acid concentration significantly decreased over time. Mean ± SE severity of nonglandular ulcers significantly increased from 0.4 ± 0.1 to 1.2 ± 0.2 over 5 weeks. Nonglandular ulcers significantly increased in number (mean ± SE, 1.3 ± 0.2 to 3.0 ± 0.2) and severity (mean ± SE, 1.2 ± 0.2 to 2.6 ± 0.2) during the 7-day alternating feed deprivation period. No effects of treatment were detected.

Conclusions and Clinical Relevance—In this model dietary oils did not prevent gastric ulcers from forming in the nonglandular portion of the stomach of horses. (Am J Vet Res 2005;66:2006–2011)

Full access
in American Journal of Veterinary Research


Objective—To determine survival time for dogs with splenic hemangiosarcoma treated with splenectomy alone, identify potential prognostic factors, and evaluate the efficacy of adjuvant chemotherapy.

Design—Retrospective case series.

Animals—208 dogs.

Procedures—Medical records were reviewed, long-term follow-up information was obtained, and survival data were analyzed statistically.

Results—154 dogs were treated with surgery alone, and 54 were treated with surgery and chemotherapy. Twenty-eight dogs received conventional chemotherapy, 13 received cyclophosphamide-based metronomic chemotherapy, and 13 received both conventional and metronomic chemotherapy. Median survival time of dogs treated with splenectomy alone was 1.6 months. Clinical stage was the only prognostic factor significantly associated with survival time. When the entire follow-up period was considered, there was no significant difference in survival time between dogs treated with surgery alone and dogs treated with surgery and chemotherapy. However, during the first 4 months of follow-up, after adjusting for the effects of clinical stage, survival time was significantly prolonged among dogs receiving any type of chemotherapy (hazard ratio, 0.6) and among dogs receiving both conventional and metronomic chemotherapy (hazard ratio, 0.4).

Conclusions and Clinical Relevance—Clinical stage was strongly associated with prognosis for dogs with splenic hemangiosarcoma. Chemotherapy was effective in prolonging survival time during the early portion of the follow-up period. Combinations of doxorubicin-based conventional protocols and cyclophosphamide-based metronomic protocols appeared to be more effective than either type of chemotherapy alone, but prolongations in survival time resulting from current protocols were modest.

Full access
in Journal of the American Veterinary Medical Association